SHORELINE BIOSCIENCES
Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients. Its proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity. The company was founded in 2020 and is headquartered in La Jolla, CA, USA.
SHORELINE BIOSCIENCES
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2020-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.shorelinebio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
186 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Investors List
Kingdon Capital
Kingdon Capital investment in Series B - Shoreline Biosciences
Eventide
Eventide investment in Series B - Shoreline Biosciences
Wedbush Securities
Wedbush Securities investment in Series B - Shoreline Biosciences
Kite Pharma
Kite Pharma investment in Series B - Shoreline Biosciences
Piper Sandler
Piper Sandler investment in Series B - Shoreline Biosciences
Commodore Capital
Commodore Capital investment in Series B - Shoreline Biosciences
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Shoreline Biosciences
BVF Partners
BVF Partners investment in Series B - Shoreline Biosciences
Superstring Capital
Superstring Capital investment in Series B - Shoreline Biosciences
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Shoreline Biosciences
Key Employee Changes
Official Site Inspections
http://www.shorelinebio.com Semrush global rank: 3.43 M Semrush visits lastest month: 4.5 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Shoreline Biosciences"
About Us - Shoreline Biosciences
Shoreline Biosciences Is Positioned to Be a Category Leader Our Vision To advance transformative therapies for autoimmune disease and cancer Our Mission To develop the right โฆSee details»
Home - Shoreline Biosciences
We are passionate about delivering novel therapies to patients in need by harnessing our cutting-edge approach in cellular immunotherapy. We are building a pipeline of iPSC-derived natural killer cell (iNK) and macrophage (iMACs) โฆSee details»
Shoreline Biosciences, Inc. - LinkedIn
Shoreline Biosciences, Inc. | 7,023 followers on LinkedIn. Clinically effective immunotherapies using intelligently engineered iPSC-derived allogeneic cells | Shoreline's proprietary cell therapy ...See details»
Shoreline Biosciences - Crunchbase Company Profile
Contact Email [email protected] Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients. Its โฆSee details»
Shoreline Biosciences and BeiGene Announce Strategic โฆ
Jun 9, 2021 SAN DIEGO, CA, CAMBRIDGE, MA & BEIJING, China โ June 9, 2021 โ Shoreline Biosciences, Inc., a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized and targeted โฆSee details»
Shoreline Biosciences, Inc.โs Post - LinkedIn
Shoreline Biosciences, Inc. is thrilled that Charles Calderaro III has officially joined our leadership team as Chief Technical Officer. Prior to joining Shoreline, Mr. Calderaro served as Global ...See details»
Shoreline Biosciences, Inc. Company Profile | San Diego, CA ...
Find company research, competitor information, contact details & financial data for Shoreline Biosciences, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Shoreline Biosciences - Craft
Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms. It focuses on the induced pluripotent stem cells (iPSC) differentiation โฆSee details»
Shoreline Biosciences - Overview, News & Similar companies
Aug 3, 2023 Shoreline Biosciences contact info: Phone number: (858) 997-2703 Website: www.shorelinebio.com What does Shoreline Biosciences do? Founded in 2020 and โฆSee details»
Shoreline Biosciences Venture Capital and Private Equity Financings
Shoreline has strategic partnerships with Kite, a Gilead Company, and BeiGene, a global biotechnology company, Contract Development and Manufacturing Organization partnerships โฆSee details»
Our Science - Shoreline Biosciences
Our Proprietary Cellular Immunotherapy Platforms With intelligent engineering, we are developing next-generation induced Pluripotent Stem Cell (iPSC)-derived natural killer (iNK) cells and macrophages (iMACs). Our platforms are built on โฆSee details»
Shoreline Biosciences - Work in biotech
Shoreline Biosciences is developing the next generation of cellular immunotherapies to win the war on cancer. Natural killer cells and macrophages are immune cells that play an important โฆSee details»
Shoreline Biosciences Announces $43m Financing - STORK CAPITAL
Feb 7, 2021 Co-founded by Stork Capital and led by Stork Capitalโs Life Sciences Chairman Kleanthis G. Xanthopoulos, Ph.D. San Diego, Calif., January 2021โ Shoreline Biosciences, โฆSee details»
Shoreline Biosciences - VentureRadar
Website: https://shorelinebio.com/ Develops proprietary cell therapy technology platform utilizing iPSC differentiation methods and IL-15/CISH pathway engineering to ...See details»
Shoreline Biosciences Enters Collaboration With BeiGene to โฆ
Palo Alto โ June 24, 2021 โ Cooley advised Shoreline Biosciences, a biotechnology company developing immunotherapies for cancer and other serious diseases, on its worldwide strategic โฆSee details»
Shoreline Biosciences reviews - Glassdoor
8 Shoreline Biosciences reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»
Shoreline Biosciences Announces $140M Financing To Advance โฆ
Nov 2, 2021 Financing accelerates the growth of Shorelineโs pipeline of iPSC-based cell immunotherapies for the treatment of seriously ill patients and enables the buildout of smart โฆSee details»
Shoreline Biosciences, Inc. (Shoreline Biosciences, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
6 days ago Abstract The full potential of cell therapy has yet to be realized in solid tumor indications and new approaches are urgently required. Macrophages are innate immune cells โฆSee details»
Kite and Shoreline Biosciences Enter Into Strategic Partnership to ...
Jun 17, 2021 -- Partnership Follows Kiteโs Investment in Shorelineโs Recent Series A Financing --SANTA MONICA, Calif. & SAN DIEGO--(BUSINESS WIRE)-- Kite, a Gilead Company โฆSee details»
Shoreline Biosciences Announces $140M Financing To Advance โฆ
Nov 2, 2021 Shoreline has strategic partnerships with Kite, a Gilead Company, and BeiGene, a global biotechnology company, Contract Development and Manufacturing Organization โฆSee details»